ARTICLE | Clinical News
Tarvacin bavituximab: Phase Ib started
June 12, 2006 7:00 AM UTC
PPHM started a U.S. Phase Ib trial in up to 24 patients with HCV infection. Each cohort will receive 4 doses of bavituximab over a 14-day period and will be followed for an additional 12 weeks. ...